RxDoctor Payments Data

Andrew Azadian

Adult Health · Lakewood, CONPI 1215272125

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,659 of the $5,795 with a category attached, or 80.4%. Cvrx, Inc. accounts for 60.1% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $3,224, 9.6 times the $337 reported in 2021. Among adult health clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,795in general payments, 2019–2025

Across 108 payments — averaging $53.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cvrx, Inc.$3K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$549
  • Impulse Dynamics (USA) Inc.$422
  • Alnylam Pharmaceuticals Inc.$202
  • Merck$178
  • Novartis$159
  • plus $803 from 14 others

What the payments were for

  • Travel & lodging$1,13620%
  • Food & beverage$4,65980%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,795 in reported general payments places this provider in the 95th percentile of 430 adult health providers in Colorado.

See all adult health providers in Colorado

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan195$280,165
FarxigaDapagliflozin Propanediol82$106,826
JardianceEmpagliflozin28$33,675
EliquisApixaban28$32,145
Metoprolol Succinate106$2,166
Torsemide77$1,887
Bumetanide44$1,420
Spironolactone114$1,064
Isosorbide Dinitrate16$852
Carvedilol44$573
Potassium Chloride47$429
Losartan Potassium24$343
Hydralazine Hcl17$290
Isosorbide Mononitrate ErIsosorbide Mononitrate18$215
Furosemide45$173

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$159$280,165195 claims
AstraZenecaFarxiga$156$106,82682 claims
PfizerEliquis$18$32,14528 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 430 adult health providers in Colorado.

Other adult health in Lakewood

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →